Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 5

1.

Association between adherence to folic acid supplements and serum folate, and plasma homocysteine among hemodialysis patients.

Leung J, Dwyer J, Hibberd P, Jacques P, Rand W, Rocco MV; HEMO Study Group.

J Ren Nutr. 2011 May;21(3):246-56. doi: 10.1053/j.jrn.2010.04.005. Epub 2010 Jul 21.

2.

Folic acid supplementation and cardiac and stroke mortality among hemodialysis patients.

Leung J, Larive B, Dwyer J, Hibberd P, Jacques P, Rand W; HEMO Study Group.

J Ren Nutr. 2010 Sep;20(5):293-302. doi: 10.1053/j.jrn.2010.01.005. Epub 2010 Mar 19.

3.

Homocysteine lowering interventions for preventing cardiovascular events.

MartĂ­-Carvajal AJ, SolĂ  I, Lathyris D, Salanti G.

Cochrane Database Syst Rev. 2009 Oct 7;(4):CD006612. doi: 10.1002/14651858.CD006612.pub2. Review. Update in: Cochrane Database Syst Rev. 2013;1:CD006612.

4.

Homocysteine and cardiovascular disease: should we treat?

Potter K.

Clin Biochem Rev. 2008 Feb;29(1):27-30. No abstract available.

5.

Rationale, design and baseline characteristics of a large, simple, randomized trial of combined folic acid and vitamins B6 and B12 in high-risk patients: the Heart Outcomes Prevention Evaluation (HOPE)-2 trial.

Lonn E, Held C, Arnold JM, Probstfield J, McQueen M, Micks M, Pogue J, Sheridan P, Bosch J, Genest J, Yusuf S; HOPE-2 Investigators.

Can J Cardiol. 2006 Jan;22(1):47-53.

Supplemental Content

Support Center